Skip to main content

Find Clinical Trials

Home
Conditions
Granulomatous Disease, Chronic, Autosomal Recessive, Cytochrome B-Positive, Type I

Clinical trial condition

Granulomatous Disease, Chronic, Autosomal Recessive, Cytochrome B-Positive, Type I

Explore clinical trials studying Granulomatous Disease, Chronic, Autosomal Recessive, Cytochrome B-Positive, Type I. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Granulomatous Disease, Chronic, Autosomal Recessive, Cytochrome B-Positive, Type I trial results

Recruiting

Lentiviral Gene Therapy for p47 AR-CGD

NCT05207657

Conditions: Granulomatous Disease, Chronic, Autosomal Recessive, Cytochrome B-Positive, Type I, P47-Phox, Deficiency of
Locations: Great Ormond Street Hospital London, United Kingdom

View Trial Details

Enrolling by Invitation

pCCLCHIM-p47 (Lentiviral Vector Transduced CD34 Plus Cells) in Patients With p47 Autosomal Recessive Chronic Granulomatous Disease (AR-CGD)

NCT06253507

Conditions: Autosomal Recessive, Chronic Disease, Chronic Granulomatous Disease, +15 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details